ストックスクリーナーアプリを入手
0.3286
3.44%
-0.009
前日終値:
$0.3376
開ける：
$0.349
24時間の取引高:
549.38K
Relative Volume:
0.69
時価総額：
$13.67M
収益：
-
当期純損益:
$-17.78M
株価収益率:
-0.5983
EPS:
-0.5492
ネットキャッシュフロー:
$-10.52M
1週間 パフォーマンス:
-11.96%
1か月 パフォーマンス:
-27.83%
6か月 パフォーマンス:
-62.53%
1年 パフォーマンス:
-89.72%
1日の値動き範囲:
$0.323
$0.35
1週間の範囲:
$0.3201
$0.3813
52週間の値動き範囲:
$0.3181
$3.56
Fibrobiologics Inc Stock (FBLG) Company Profile
FBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.3265 | 18.36M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.48 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
682.98 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.17 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
895.15 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
192.06 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-24 | 開始されました | Maxim Group | Buy |
Fibrobiologics Inc (FBLG) 最新ニュース
Should you hold or exit FibroBiologics Inc. now2025 Market Overview & Accurate Buy Signal Alerts - newser.com
What earnings revisions data tells us about FibroBiologics Inc.2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Why FibroBiologics Inc. (SG0) stock could outperform next yearQuarterly Market Review & Weekly Top Gainers Trade List - newser.com
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com
How FibroBiologics Inc. (SG0) stock benefits from digital adoptionEarnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
How FibroBiologics Inc. stock performs in interest rate cyclesJuly 2025 Summary & Daily Price Action Insights - newser.com
What’s the recovery path for long term holders of FibroBiologics Inc.Quarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
What data driven models say about FibroBiologics Inc.’s futureQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Is FibroBiologics Inc. (SG0) stock good for long term investingWeekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Is FibroBiologics Inc. (SG0) stock included in top ETFsGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
How FibroBiologics Inc. (SG0) stock performs in easing cyclesMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Why FibroBiologics Inc. stock appeals to dividend seekersQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
Is FibroBiologics Inc. stock gaining market shareWeekly Trend Report & Technical Entry and Exit Tips - newser.com
Why institutional investors increase stakes in FibroBiologics Inc. (SG0) stock2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Is FibroBiologics Inc. (SG0) stock resilient in recession scenarios2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Identifying reversal signals in FibroBiologics Inc.New Guidance & Free Technical Pattern Based Buy Signals - newser.com
Real time scanner hits for FibroBiologics Inc. explainedInflation Watch & Verified Stock Trade Ideas - newser.com
FibroBiologics price target lowered to $5 from $10 at H.C. Wainwright - MSN
How dovish Fed policy supports FibroBiologics Inc. (SG0) stockEarnings Performance Report & Risk Managed Trade Strategies - newser.com
When is the best time to exit FibroBiologics Inc.Chart Signals & Community Trade Idea Sharing Platform - newser.com
H.C. Wainwright cuts FibroBiologics stock price target to $5 on clinical timeline - Investing.com Australia
Why FibroBiologics Inc. stock is recommended by analysts2025 Momentum Check & Advanced Technical Analysis Signals - fcp.pa.gov.br
FBLG: HC Wainwright & Co. Lowers Price Target Despite Buy Rating - GuruFocus
FBLG: HC Wainwright & Co. Lowers Price Target Despite Buy Rating | FBLG Stock News - GuruFocus
HC Wainwright & Co. Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
Fibrobiologics Inc (FBLG) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.82%
大文字化:
|
ボリューム (24 時間):